US Stock MarketDetailed Quotes
NMTC NeuroOne Medical
- 1.1600
- +0.0300+2.65%
Close May 1 16:00 ET
30.08MMarket Cap-1705P/E (TTM)
1.1800High1.1000Low84.63KVolume1.1800Open1.1300Pre Close96.66KTurnover0.43%Turnover RatioLossP/E (Static)25.93MShares2.000052wk High6.82P/B22.64MFloat Cap0.850052wk Low--Dividend TTM19.52MShs Float7.9700Historical High--Div YieldTTM7.08%Amplitude0.5101Historical Low1.1420Avg Price1Lot Size
NeuroOne Medical Key Stats
Quarterly+Annual
YOY
| (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (Q3)Jun 30, 2022 | (Q2)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -9.08%-3.81M | -71.38%-12.89M | -385.20%-2.9M | -11.52%-2.94M | -10.24%-3.55M | -30.35%-3.49M | 12.59%-7.52M | 150.16%1.02M | -15.17%-2.64M | -35.37%-3.22M |
| Net income from continuing operations | -93.04%-3.34M | -18.60%-11.86M | -128.12%-3.14M | -25.69%-3.47M | -15.20%-3.52M | 38.28%-1.73M | -0.52%-10M | 48.00%-1.37M | 6.50%-2.76M | -27.74%-3.06M |
| Operating gains losses | ---- | --32.14K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 63.44%58.66K | 67.99%199.27K | 87.03%62.51K | 80.78%56.96K | 53.90%43.91K | 42.64%35.89K | 46.90%118.62K | 49.45%33.42K | 54.78%31.51K | 47.87%28.53K |
| Other non cash items | 7.80%28.86K | -48.23%109.83K | -78.61%28.27K | 2.09%27.68K | 1.66%27.11K | 2.05%26.77K | 205.54%212.16K | 21.61%132.14K | 139.25%27.12K | 105.88%26.67K |
| Change In working capital | 59.05%-860.65K | -300.11%-2.43M | -108.17%-161.87K | 179.58%152.04K | 29.75%-317.12K | -1,566.20%-2.1M | 336.69%1.21M | 784.87%1.98M | -13.77%-191.07K | -31.02%-451.44K |
| -Change in receivables | -775.29%-543.4K | 120.13%33.24K | --0 | 484.82%213.95K | -892.25%-118.63K | -361.86%-62.08K | 131.24%15.1K | -303.36%-33.24K | 191.24%36.58K | -116.73%-11.96K |
| -Change in inventory | 159.31%118.03K | -68.60%-1.02M | 16.02%-210.16K | -47.27%-342.22K | -3,854.20%-270.75K | -52.12%-199.02K | -516.82%-606.25K | -442.79%-250.25K | -345.33%-232.38K | -47.80%7.21K |
| -Change in prepaid assets | -94.96%3.78K | 122.61%32.9K | -66,719.23%-52.12K | 758.57%159.08K | 16.12%-149K | 449.11%74.95K | -1,649.28%-145.54K | -100.21%-78 | 122.27%18.53K | -496.18%-177.64K |
| -Change in payables and accrued expense | 4.60%-439.06K | -175.50%-1.47M | -95.57%100.41K | 978.75%121.23K | -348.00%-1.23M | -1,650.96%-460.22K | 645.08%1.95M | 839.94%2.27M | -282.83%-13.8K | 41.98%-275.43K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | -22,730.06%-1.46M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -9.08%-3.81M | -71.38%-12.89M | -385.20%-2.9M | -11.52%-2.94M | -10.24%-3.55M | -30.35%-3.49M | 12.59%-7.52M | 150.16%1.02M | -15.17%-2.64M | -35.37%-3.22M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -346.41%-37.13K | 181.67%2.65M | 98.35%-50.12K | 1,687.03%860.71K | 2,054.91%1.82M | 124.51%15.07K | -4,737.23%-3.24M | -8,546.56%-3.04M | -81.32%-54.23K | -4,432.25%-93.32K |
| Net PPE purchase and sale | -222.54%-37.13K | -36.84%-376.62K | 24.27%-50.12K | -156.83%-139.29K | -88.27%-175.69K | 81.28%-11.51K | -310.30%-275.23K | -88.50%-66.18K | -81.32%-54.23K | -4,432.25%-93.32K |
| Net investment purchase and sale | --0 | 201.92%3.03M | --0 | --1M | --2M | --26.58K | ---2.97M | ---2.97M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -346.41%-37.13K | 181.67%2.65M | 98.35%-50.12K | 1,687.03%860.71K | 2,054.91%1.82M | 124.51%15.07K | -4,737.23%-3.24M | -8,546.56%-3.04M | -81.32%-54.23K | -4,432.25%-93.32K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 7,768.90%1.21M | -38.46%7.4M | 5.19M | 1.56M | 205,677.95%661.96K | -100.13%-15.71K | 4.23%12.02M | 0 | 0 | -100.00%-322 |
| Net common stock issuance | --1.24M | -36.55%8.47M | --6.03M | --1.61M | --829.61K | --0 | 51.21%13.35M | --0 | --0 | --0 |
| Net other financing activities | -139.92%-37.7K | 19.26%-1.07M | ---836.94K | ---51.37K | -51,963.98%-167.65K | 98.82%-15.71K | -6.16%-1.33M | --0 | --0 | 99.99%-322 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 7,768.90%1.21M | -38.46%7.4M | --5.19M | --1.56M | 205,677.95%661.96K | -100.13%-15.71K | 4.23%12.02M | --0 | --0 | -100.00%-322 |
| Net cash flow | ||||||||||
| Beginning cash position | -34.78%5.32M | 18.24%8.16M | -69.71%3.08M | -72.01%3.6M | -71.16%4.67M | 18.24%8.16M | 70.98%6.9M | 13.21%10.18M | 14.15%12.87M | 127.02%16.18M |
| Current changes in cash | 24.37%-2.64M | -325.41%-2.84M | 210.96%2.24M | 80.72%-518.71K | 67.87%-1.07M | -137.63%-3.49M | -56.06%1.26M | 3.42%-2.02M | -17.84%-2.69M | -179.98%-3.32M |
| End cash Position | -42.56%2.68M | -34.78%5.32M | -34.78%5.32M | -69.71%3.08M | -72.01%3.6M | -71.16%4.67M | 18.24%8.16M | 18.24%8.16M | 13.21%10.18M | 14.15%12.87M |
| Free cash flow | -9.78%-3.85M | -70.26%-13.27M | -411.09%-2.96M | -14.44%-3.08M | -12.44%-3.73M | -27.85%-3.5M | 10.09%-7.79M | 146.10%951.64K | -16.02%-2.69M | -39.17%-3.31M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg